Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 30, 2020
Safety and Clinical Activity of Atezolizumab Plus Bevacizumab in Patients with Ovarian Cancer: A Phase Ib StudyJohn W Moroney, John Powderly, Christopher H Lieu, et al.
Blood|June 1, 2006
Fetal hemoglobin silencing in humansPatricia A Oneal, Nicole M Gantt, Joseph D Schwartz, et al.
The Journal of Clinical Investigation|June 7, 2022
Epigenetic priming enhances antitumor immunity in platinum-resistant ovarian cancerSiqi Chen, Ping Xie, Matthew Cowan, et al.
Gynecologic Oncology|January 22, 2022
A randomized phase II trial of everolimus and letrozole or hormonal therapy in women with advanced, persistent or recurrent endometrial carcinoma: A GOG Foundation studyBrian M Slomovitz, Virginia L Filiaci, Joan L Walker, et al.
Molecular Cancer Therapeutics|January 11, 2011
PIK3CA mutations in patients with advanced cancers treated with PI3K/AKT/mTOR axis inhibitorsFilip Janku, Apostolia M Tsimberidou, Ignacio Garrido-Laguna, et al.
Gynecologic Oncology|April 12, 2025
An open-label randomized active-controlled phase II clinical study to assess the efficacy and safety of afuresertib plus paclitaxel versus paclitaxel in patients with platinum-resistant ovarian cancer (PROFECTA-II/GOG-3044)Thomas J Herzog, John B Liao, Karen Finkelstein, et al.
Nature Medicine|August 28, 2007
High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidinToshihiko Tanno, Natarajan V Bhanu, Patricia A Oneal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2021
Phase I Study of Stereotactic Body Radiotherapy plus Nivolumab and Urelumab or Cabiralizumab in Advanced Solid TumorsCorey C Foster, Gini F Fleming, Theodore G Karrison, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2020
Improved Survival Associated with Local Tumor Response Following Multisite Radiotherapy and Pembrolizumab: Secondary Analysis of a Phase I TrialJason J Luke, Benjamin E Onderdonk, Sandeep R Bhave, et al.
JAMA Oncology|June 14, 2019
Single-Arm Phases 1 and 2 Trial of Niraparib in Combination With Pembrolizumab in Patients With Recurrent Platinum-Resistant Ovarian CarcinomaPanagiotis A Konstantinopoulos, Steven Waggoner, Gregory A Vidal, et al.
Pageof 3